From December 7, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on December 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.21 USD | -0.14% | +0.06% | +18.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.31% | 54.44B | |
+11.31% | 225B | |
+15.50% | 197B | |
+18.83% | 143B | |
+30.38% | 111B | |
+2.62% | 64.72B | |
+4.96% | 51.06B | |
+9.95% | 45.03B | |
+4.27% | 37.4B | |
+26.89% | 32.07B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on December 7, 2023.